Human Resources
Talent acquisition and retention: The current state of play in biopharma and medtech sectors

Human Resources: Evolving employer and employee preferences are significantly influencing talent acquisition and retention outcomes.
Maree Paras, Associate Director, Paras and Partners and Vanessa Meikle, Founder & CEO, Hunton Executive joined Health Industry Hub to deep dive into the current state of talent acquisition and retention across the pharma, medtech and biotech sectors, including “The great resignation or the great rethink?”
According to recent Gartner data, 30% of the skills that were present in job descriptions three years ago will be obsolete in 2022. Vanessa and Maree shared their views on the top workforce skills (soft and hard skills) that are critical in the current ecosystem and the importance of employee investment and commitment in lifelong learning to fulfil what employers define as the “ideal candidate”.
Finally, the duo considered the biggest changes and movements in the current workforce and how this will be evolving in the next 6 months.
News - MedTech & Diagnostics
Hearts4heart takes aim at health insurers leaving patients to pay the price
Persistent advocacy by patient groups has prompted the Medical Services Advisory Committee (MSAC) to review the funding gaps for pulsed […]
MoreNews - MedTech & Diagnostics
Queensland first: Private hospitals deploy Abbott’s PFA in atrial fibrillation
More Australians living with atrial fibrillation (AF) are gaining access to one of the latest advances in heart-rhythm treatment, with […]
MoreNews - Pharmaceuticals
Five years of HTA reform talk, now comes the $47 billion question
Medicines Australia has put a $47 billion price tag on what it says Australia must invest to improve equitable access […]
MoreNews - Pharmaceuticals
New MFN deals raise the stakes for Australia’s delayed HTA reform
Four months after the US Trump administration concluded what was expected to be the final tranche of drug-pricing agreements with […]
More